Holder evidence
2
SEC ownership of Deciphera Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001654151.
Largest current holder
Brightstar Associates LLC
13D/G signal
—
Latest evidence
22 Apr 2024
- Ownership evidence mix
- 3/4/5
- Largest current holder
- Brightstar Associates LLC
- Latest evidence date
- 22 Apr 2024
- CIK
- 0001654151
- Location
- Waltham, MA
Ownership snapshot
1 fact
Issuer identity
2 facts
Ownership snapshot
Top shareholders of Deciphera Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Brightstar Associates LLC
13D/G signal
—
Evidence rows
2
Latest as of
22 Apr 2024
3/4/5
Highest disclosed value: $360,891,375
Quick read
Brightstar Associates LLC has the largest disclosed position value at $360.89M.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Disclosed position value
Top 2
Brightstar Associates LLC
$360.89M
Daniel Lee Flynn
$5.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Brightstar Associates LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$360,891,375
23,107,844 shares
|
— | 22 Apr 2024 |
| Daniel Lee Flynn |
3/4/5
Chief Scientific Officer
|
—
class O/S missing
|
$5,478,417
378,613 shares
|
— | 16 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to Deciphera Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest current holder
Brightstar Associates LLC
Net 12M change
$0
Latest report
11 Jun 2024
Recent insider transactions for Deciphera Pharmaceuticals, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.